H.C. Wainwright analyst Pat Trucchio adjusted the price target for Cybin Inc. (NYSE:CYBN) stock, lowering it to $150.00 from the previous $190.00 while maintaining a Buy rating on the company.

Mental health professionals reveal the hidden signs of anxiety disorders affecting millions of Americans, from mysterious ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience treatments with several clinical programs from Swiss major Roche in hand. | ...

Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.

Anxiety has become a buzzword in today’s world, but for kids and teens, it’s more than just a passing worry—it’s a growing crisis. Let's get creative in how we treat it!

Political anxiety has become a dominant theme in our culture. We present some of the prominent features and suggestions about ...

More than four hours before police arrived, Denise Lozano, a longtime employee of Vista-based natural soap maker Dr.

Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“ Cybin ” or the “ Company ”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing ...

You're probably familiar with the symptoms of anxiety: feeling worried, racing thoughts, and being irritable. But while being ...

A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...